Search & Analyze
Popular Searches
Bal Pharma Ltd.
Healthcare₹87.080.26%
24 Jul, 4:01 PM
CMP₹87.08
Mkt Cap₹140 Cr
P/E22.35
P/B1.71
ROE9.69%
52W High₹112.97
52W Low₹59.69
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
22.35
P/B Ratio
1.71
EV/EBITDA
8.65
Price/Sales
0.45
Dividend Yield (%)
1.36
EPS (TTM ₹)
3.95
Book Value (₹)
51.65
ROE (%)
9.69
ROCE (%)
10.10
ROA (%)
2.21
EBITDA Margin (%)
9.82
Net Profit Margin (%)
2.39
Debt/Equity
1.94
Current Ratio
1.07
Interest Coverage
1.30
Asset Turnover
0.93
Working Capital/Sales
19.72
Core EBITDA Growth (%)
-5.39
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 25052.86 | 28121.46 | 30421.63 | 33921.96 | 30308.33 |
| Net Sales | 25052.86 | 28121.46 | 30421.63 | 33921.96 | 30308.33 |
| Total Income | 25166.7 | 28636.66 | 30515.69 | 34206.78 | 30528.62 |
| Total Expenditure | 22588.48 | 25723.53 | 27896.63 | 30828.41 | 27332.36 |
| Operating Profit | 2578.22 | 2913.13 | 2619.06 | 3378.37 | 3196.26 |
| Depreciation | 952.13 | 904.01 | 912.83 | 1007.11 | 977.09 |
| Exceptional Items | — | — | — | — | — |
| Profit Before Tax | 410.26 | 918.24 | 474.85 | 904.73 | 513.74 |
| Tax | -60.95 | 347.75 | 212.92 | 160.16 | -209.93 |
| Profit After Tax (PAT) | 471.21 | 570.49 | 261.93 | 744.57 | 723.67 |
| EPS (₹) | 3.34 | 3.79 | 1.67 | 4.96 | 4.54 |
| Dividend Payout % | 10 | 10 | 10 | 12 | 12 |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 1482.24 | 1482.24 | 1568.99 | 1580.44 | 1592.09 |
| Reserves | 3782.15 | 4286.67 | 4809.92 | 5620 | 6149.5 |
| Shareholders Funds | 5358.14 | 5862.66 | 6378.91 | 7200.44 | 7741.59 |
| Total Debt | 11002.29 | 10364.08 | 13099.92 | 13959.9 | 15038.02 |
| Total Liabilities | 24008.06 | 26053.32 | 31100.58 | 31983.87 | 33528.03 |
| Total Assets | 24008.06 | 26053.32 | 31100.58 | 31983.87 | 33528.03 |
| Book Value / Share | 35.5164 | 38.9202 | 40.6562 | 45.5597 | 48.6253 |
| Assets | 24008.06 | 26053.32 | 31100.58 | 31983.87 | 33528.03 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 2233.52 | 2679.55 | -153.71 | 2280.58 | 2031.5 |
| Investing Activities | -553.45 | -948.48 | -2218.23 | -1889.09 | -1491.69 |
| Financing Activities | -1663.23 | -1722.16 | 2409.38 | -120.63 | -784.24 |
| Net Cash Flow | 16.84 | 8.91 | 37.44 | 270.86 | -244.43 |
BALPHARMA
₹87.08
+0.26%